80-OR: Treatment with Once-Weekly Semaglutide 2.4 mg Improves Cardiometabolic Risk Factors in Adults with Overweight/Obesity and Type 2 Diabetes: STEP 2 Post-hoc Analysis
Keyword(s):
Keyword(s):
Keyword(s):
2013 ◽
Vol 1
(1)
◽
pp. 43-51
◽
Keyword(s):
2018 ◽
Vol 107
(6)
◽
pp. 921-931
◽
Keyword(s):
2019 ◽
Vol 7
(1)
◽
pp. e000787
◽
2007 ◽
Vol 2
(3)
◽
pp. 331-339